NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for NASDAQ stock CUE Cue Biopharma. Dated: 21 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 25.55 and Closed at: 23.98, which is -2.63% of previous session's close. It moved within a range of 23.24 and 26.00
The session was a Bearish session with an average volume of 177700, which is 11.09% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

Support for tomorrow is 22.23 and resistance for tomorrow is 24.99
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 22.81, 21.65 resistance for tomorrow's hourly charts is 25.57, 27.17

10 Day SMA for Cue Biopharma (CUE) is 27.83 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 28.04 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 29.27 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 23.61 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Cue Biopharma is 12 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Cue Biopharma is at 28.04 and 200 DMA is at 12, while 50 DMA and 100 DMA are at 29.27 and 23.61 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 28.04 and 20 EMA is at 27.98

Cue Biopharma (CUE) moving average of 50 SMA is at 29.27 and 50 EMA is at 27.63

Cue Biopharma (CUE) moving average of 100 SMA is at 23.61 and 100 EMA is at 23.28

Cue Biopharma (CUE) moving average of 200 SMA is at 12 and 200 EMA is at 16.41

Xenon Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 18.75% more returns!

Solid Biosciences has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Solid Biosciences, about 44.24% more returns!

Cue Biopharma has performed better than Nature S in short term. Holding Cue Biopharma could be a better choice for now!

Mannkind Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Mannkind Corporation, about 31.17% more returns!

Cue Biopharma has performed better than Moleculin Biotech in short term. Holding Cue Biopharma could be a better choice for now!

Microbot Medical has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Microbot Medical, about 12.58% more returns!

Lexicon Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Lexicon Pharmaceuticals, about 29.51% more returns!

Lakeland Industries has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Lakeland Industries, about 30.83% more returns!

Acadia Healthcare has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Acadia Healthcare, about 11.97% more returns!

Achieve Life has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Achieve Life, about 55.66% more returns!

Adma Biologics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Adma Biologics, about 42.41% more returns!

Argenx Se has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Argenx Se, about 43.35% more returns!

Cue Biopharma has performed better than Curis Inc in short term. Holding Cue Biopharma could be a better choice for now!

Halozyme Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 59.13% more returns!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a SELL signal for Cue Biopharma in short term and the sell signal is strong.

Cue Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Cue Biopharma in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Cue Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 27.78 and Cue Biopharma CUE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet